Clinical Trial Update: Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox) [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 efficacy and safety trial comparing JNJ-32729463 to Linezolid for complicated skin and skin-structure infection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Skin and Skin Structure Infections

Drugs mentioned

• JNJ-32729463
• ZYVOX (LINEZOLID)

Snippet

Sponsor: Furiex Pharmaceuticals, Inc | Conditions: Complicated Skin and Skin Structure Infections | Phase 2 | Status: COMPLETED